(Vildagliptin)
The active substance of AGNIS is vildagliptin, which belongs to a group of medicines called oral anti-diabetic medicines.
AGNIS is a medicine used to treat type 2 diabetes in adults who are unable to control their condition with diet and exercise alone. This medicine helps to keep blood sugar levels under control. Your doctor may prescribe AGNIS as the only anti-diabetic medicine or in combination with other anti-diabetic medicines that you have taken before, if they have not been effective enough in controlling your blood sugar levels.
Type 2 diabetes is a condition where the body does not produce enough insulin or the insulin produced by the body does not work properly. Diabetes can also develop if the body produces too much glucagon.
Insulin is a substance that helps to lower blood sugar levels, especially after meals.
Glucagon is a substance that stimulates the production of sugar in the liver and increases blood sugar levels.
Both of these substances are produced in the pancreas.
The action of this medicine is to stimulate the pancreas to produce insulin and reduce the production of glucagon. Therefore, it helps to keep blood sugar levels under control. It has been shown that the medicine reduces blood sugar levels, which can help prevent complications of diabetes. Despite starting pharmacological treatment for diabetes, it is essential for the patient to continue following a suitable diet and (or) performing recommended physical exercises.
If you have previously taken vildagliptin but had to stop due to liver disease, you should not take this medicine.
Skin conditions are a common complication of diabetes. You should follow your doctor's or nurse's advice on skin and foot care. While taking AGNIS, you should pay particular attention to the appearance of new blisters or ulcers. If they appear, you should contact your doctor immediately.
Before starting to take AGNIS and at 3-month intervals during the first year of treatment, and periodically thereafter, you should have liver function tests. This will help to find out as soon as possible if you have any signs of liver damage.
AGNIS should not be used in children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Your doctor may need to adjust the dose of AGNIS if you are taking other medicines, such as:
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take AGNIS if you are pregnant. It is not known if AGNIS passes into breast milk. Do not take AGNIS if you are breastfeeding or planning to breastfeed.
If you experience dizziness while taking AGNIS, do not drive or operate machinery.
AGNIS contains lactose (a sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, which is essentially 'sodium-free'.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The dose of AGNIS varies depending on your condition. Your doctor will decide exactly how many tablets of AGNIS to take. The maximum daily dose is 100 mg.
The usual dose is:
If you have taken too many tablets, contact your doctor immediately. You may need medical attention. If you need to go to a doctor's office or hospital, take the package leaflet with you.
If you forget to take a dose, take it as soon as you remember. Then take your next dose at the usual time. However, if it is almost time for your next dose, skip the missed dose. Do not take a double dose to make up for a forgotten tablet.
Do not stop taking AGNIS unless your doctor tells you to. If you have any questions about how long to take this medicine, ask your doctor.
Like all medicines, AGNIS can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking AGNIS and contact your doctor immediately:
In some patients taking AGNIS and metformin, the following side effects have occurred:
In some patients taking AGNIS and a sulfonylurea, the following side effects have occurred:
In some patients taking AGNIS and a glitazone, the following side effects have occurred:
In some patients taking AGNIS alone, the following side effects have occurred:
In some patients taking AGNIS, metformin, and a sulfonylurea, the following side effects have occurred:
In some patients taking AGNIS and insulin (with or without metformin), the following side effects have occurred:
If you experience any side effects, including any not listed in this leaflet, please tell your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.
There are no special storage instructions for this medicine.
Do not use this medicine if the packaging is damaged or shows signs of tampering.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
AGNIS 50 mg is a white or almost white, round, uncoated tablet with a diameter of 8 mm, with beveled edges, with the inscription "50" on one side and smooth on the other side.
The medicine is available in packs of 28, 30, 56, 60, or 180 tablets.
Not all pack sizes may be marketed.
Belupo pharmaceuticals and cosmetics Inc.
Danica 5
48000 Koprivnica
Croatia
Croatia
AGNIS 50 mg tablets
Czech Republic
AGNIS
Poland
AGNIS
Slovakia
AGNIS 50 mg tablets
Slovenia
AGNIS 50 mg tablets
Date of last revision of the leaflet:04/2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.